Call athenahealthMenu

athenahealth, Inc. Reports Fourth Quarter and Full Year 2010 Results

  • 27% Revenue Growth Over Fourth Quarter of 2009
  • GAAP Net Income of $7.3 Million, or $0.21 Per Diluted Share
  • Non-GAAP Adjusted Net Income of $9.8 Million, or $0.28 Per Diluted Share

WATERTOWN, Mass., Feb 17, 2011 (BUSINESS WIRE) -- athenahealth, Inc. (Nasdaq: ATHN), (the "Company"), a leading provider of Internet-based business services for physician practices, today announced financial and operational results for the fourth quarter and full year of 2010. The Company will conduct a conference call tomorrow, Friday, February 18, 2011, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.

Total revenue for the three months ended December 31, 2010, was $69.4 million, compared to $54.4 million in the same period last year, an increase of 27%. Full year 2010 revenue was $245.5 million, compared to full year 2009 revenue of $188.5 million, an increase of 30%.

"We delivered strong top and bottom line performance during 2010, but I am most proud of the heavy lifting we did at the same time," said Jonathan Bush, the Company's Chairman, President, and Chief Executive Officer. "We launched a new service offering, expanded our sales, marketing and implementation capacity, achieved Meaningful Use certification, and piloted a new business model for electronic health information exchange, all while delivering more value to our clients."

For the three months ended December 31, 2010, non-GAAP Adjusted EBITDA grew to $20.2 million, or 29% of revenue, from non-GAAP Adjusted EBITDA of $13.0 million, or 24% of revenue, in the same period last year. GAAP net income for the fourth quarter of 2010 was $7.3 million, or $0.21 per diluted share, and non-GAAP Adjusted Net Income was $9.8 million, or $0.28 per diluted share.

"Our investments in growth and innovation during 2010 are a sign of our confidence in athenahealth's potential to become a multi-billion dollar company" said Tim Adams, the Company's Chief Financial Officer. "We achieved annual revenue growth in excess of 30% for the 11th year in a row and our efforts to enhance operational efficiency yielded record profitability levels."

For the year ended December 31, 2010, non-GAAP Adjusted EBITDA grew to $51.0 million, or 21% of revenue, from non-GAAP Adjusted EBITDA for 2009 of $34.7 million, or 18% of revenue. For 2010, GAAP net income was $12.7 million, or $0.36 per diluted share. Non-GAAP Adjusted Net Income for the year was $22.6 million, or $0.64 per diluted share.

Key metrics and milestones in the fourth quarter and full year of 2010 included the following:

  • $1.6 billion in collections posted to client accounts in the fourth quarter of 2010, compared to $1.4 billion in the same quarter of 2009
  • $5.9 billion in collections posted to client accounts in all of 2010, compared to $4.9 billion in all of 2009
  • 38.8 average Client Days in Accounts Receivable (DAR) in the fourth quarter of 2010, compared to 38.5 average Client DAR in the same quarter of 2009
  • 27,114 active medical providers using athenaCollector(R) at December 31, 2010, 19,197 of which were physicians, compared to 23,366 providers and 15,719 physicians at December 31, 2009
  • 3,348 active medical providers using athenaClinicals(R)at December 31, 2010, 2,383 of which were physicians, compared to 1,471 providers and 920 physicians at December 31, 2009
  • 1,213 active medical providers using athenaCommunicator(R) at December 31, 2010, 736 of which were physicians

As of December 31, 2010, the Company had cash, cash equivalents, short- and long-term investments of $121.8 million and short- and long-term debt and capital lease obligations of $9.2 million.

Use of Non-GAAP Financial Measures

In the Company's earnings releases, conference calls, slide presentations, or webcasts, the Company may use or discuss non-GAAP financial measures as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. The Company's earnings press releases containing such non-GAAP reconciliations can be found on the Investors section of the Company's web site at www.athenahealth.com.

Conference Call Information

To participate in the Company's live conference call and webcast, please dial 800-435-1261 (617-614-4076 for international calls) using conference code No. 15398557 or visit the Investors section of the Company's web site: www.athenahealth.com. A replay will be available for one week following the conference call at 888-286-8010 (617-801-6888 for international calls) using conference code No. 52965842. A webcast replay will also be archived on the Company's website.

About athenahealth

athenahealth, Inc. is a leading provider of web-based business services for medical groups. athenahealth's service offerings are based on proprietary web-native practice management and electronic health record (EHR) software, a continuously updated payer knowledge-base, integrated back-office service operations, and automated and live patient communication services. For more information, please visit www.athenahealth.com or call (888) 652-8200.

Forward-Looking Statements

This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements reflecting management's expectations for future financial and operational performance and operating expenditures, expected growth, including anticipated annual growth rates, profitability and business outlook, the benefits of the Company's current service offerings, and statements found under the Company's Reconciliation of Non-GAAP Financial Measures section of this release. The forward-looking statements in this release do not constitute guarantees of future performance. These statements are neither promises nor guarantees, and are subject to a variety of risks and uncertainties, many of which are beyond the Company's control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: the Company's fluctuating operating results; the Company's variable sales and implementation cycles, which may result in fluctuations in its quarterly results; risks associated with its expectations regarding its ability to maintain profitability; the impact of increased sales and marketing expenditures, including whether increased expansion in revenues is attained and whether impact on margins and profitability is longer term than expected; changes in tax rates or exposure to additional tax liabilities; the highly competitive industry in which the Company operates and the relative immaturity of the market for its service offerings; and the evolving and complex governmental and regulatory compliance environment in which the Company and its clients operate. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances, or otherwise. For additional disclosure regarding these and other risks faced by the Company, see the disclosures contained in its public filings with the Securities and Exchange Commission, available on the Investors section of the Company's website at www.athenahealth.com and on the SEC's website at www.sec.gov.

athenahealth, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except per share amounts)

December 31 December 31
2010 2009
Assets
Current assets:
Cash and cash equivalents $ 35,944 $ 30,526
Short-term investments 80,231 52,323
Accounts receivable - net 36,870 33,323
Deferred tax assets 3,856 5,544
Prepaid expenses and other current assets 6,749 4,663
Total current assets 163,650 126,379
Property and equipment - net 31,899 24,871
Restricted cash 8,691 9,216
Software development costs - net 3,642 2,324
Purchased intangibles - net 12,651 14,490
Goodwill 22,450 22,120
Deferred tax assets 10,959 10,284
Investments and other assets 7,228 1,393
Total assets $ 261,170 $ 211,077
Liabilities and Stockholders' Equity
Current liabilities:
Current portion of long-term debt and capital lease obligations $ 2,909 $ 3,437
Accounts payable 559 1,880
Accrued compensation 19,178 15,774
Accrued expenses 10,981 10,781
Current portion of deferred revenue 4,978 4,038
Interest rate derivative liability 490 291
Current portion of deferred rent 1,497 1,288
Total current liabilities 40,592 37,489
Deferred rent, net of current portion 5,960 7,444
Deferred revenue, net of current portion 35,661 28,684
Other long-term liabilities 1,897 1,191
Debt and capital lease obligations, net of current portion 6,307 8,951
Total liabilities 90,417 83,759
Preferred stock; $0.01 par value: 5,000 shares authorized and no shares issued
and outstanding at December 31, 2010 and 2009, respectively - -
Common stock; $0.01 par value per share; 125,000 shares authorized;
35,808 shares issued and 34,530 shares outstanding at December 31, 2010
35,166 shares issued and 33,888 shares outstanding at December 31, 2009 358 352
Additional paid-in capital 200,339 169,715
Treasury stock, at cost, 1,278 shares (1,200 ) (1,200 )
Accumulated other comprehensive income (loss) 28 (73 )
Accumulated deficit (28,772 ) (41,476 )
Total stockholders' equity 170,753 127,318
Total liabilities and stockholders' equity $ 261,170 $ 211,077

athenahealth, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share amounts)

Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
Revenue:
Business services $ 67,094 $ 53,297 $ 237,145 $ 183,230
Implementation and other 2,272 1,149 8,393 5,297
Total revenue 69,366 54,446 245,538 188,527
Expenses:
Direct operating 24,419 21,117 96,582 79,017
Selling and marketing 14,689 9,222 52,675 34,072
Research and development 4,905 3,980 18,448 14,348
General and administrative 9,649 9,784 43,119 36,111
Depreciation and amortization 3,171 2,232 11,117 7,767
Total expenses 56,833 46,335 221,941 171,315
Operating income 12,533 8,111 23,597 17,212
Other income (expense):
Interest income 90 78 309 1,016
Interest expense (316 ) (241 ) (753 ) (968 )
(Loss) gain on interest rate derivative contract 276 215 (199 ) 590
Other income 50 44 146 255
Total other (expense) income 100 96 (497 ) 893
Income before income taxes 12,633 8,207 23,100 18,105
Income tax provision (5,330 ) (3,879 ) (10,396 ) (8,829 )
Net income $ 7,303 $ 4,328 $ 12,704 $ 9,276
Net income per share - Basic $ 0.21 $ 0.13 $ 0.37 $ 0.28
Net income per share - Diluted $ 0.21 $ 0.12 $ 0.36 $ 0.27
Weighted average shares used in computing net income per share:
Basic 34,419 33,785 34,181 33,584
Diluted 35,278 35,133 35,204 34,917

athenahealth, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

Years Ended December 31,
2010 2009 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 12,704 $ 9,276 $ 31,602
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 12,956 8,403 6,095
Amortization of premiums (discounts) on investments 1,152 (113 ) (899 )
Provision for uncollectible accounts 1,772 999 405
Decrease in fair value of contingent consideration (250 ) - -
Loss (gain) on interest rate derivative contract 199 (590 ) 881
Deferred income taxes 1,013 5,918 (23,833 )
Excess tax benefit from stock-based awards (9,245 ) (2,505 ) (526 )
Stock-based compensation expense 14,477 8,314 5,558
Loss (gain) on disposal of property and equipment - 276 (47 )
Changes in operating assets and liabilities:
Accounts receivable (5,319 ) (10,489 ) (9,254 )
Prepaid expenses and other current assets 5,461 (887 ) (912 )
Other assets (243 ) (173 ) 86
Accounts payable (1,024 ) 1,379 (1,195 )
Accrued expenses 4,425 6,201 7,424
Deferred revenue 7,917 7,438 7,120
Deferred rent (1,275 ) (1,118 ) (1,446 )
Net cash provided by operating activities 44,720 32,329 21,059
CASH FLOWS FROM INVESTING ACTIVITIES:
Capitalized software development costs (3,881 ) (2,555 ) (1,393 )
Purchases of property and equipment (15,932 ) (10,277 ) (13,452 )
Proceeds from sales and disposals of property and equipment 363 4,538 4,112
Purchase in long-term investment in unconsolidated company - (550 ) (550 )
Proceeds from sales and maturities of investments 110,741 84,014 73,250
Purchases of short-term and long-term investments (145,443 ) (78,588 ) (129,935 )
Payments for acquisitions, net of cash acquired - (22,391 ) (6,680 )
Decrease (increase) in restricted cash 525 (7,368 ) (136 )
Net cash used in investing activities (53,627 ) (33,177 ) (74,784 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options 8,606 2,676 5,235
Debt issuance costs - - (177 )
Excess tax benefit from stock-based awards 9,245 2,505 526
Proceeds from long-term debt - - 6,000
Payment of contingent consideration accrued at acquisition date (195 ) - -
Payments on long-term debt and capital lease obligations (3,535 ) (2,514 ) (777 )
Net cash provided by financing activities 14,121 2,667 10,807
Effects of exchange rate changes on cash and cash equivalents 204 (226 ) (40 )
Net increase (decrease) in cash and cash equivalents 5,418 1,593 (42,958 )
Cash and cash equivalents at beginning of year 30,526 28,933 71,891
Cash and cash equivalents at end of year $ 35,944 $ 30,526 $ 28,933
Supplemental disclosures of non-cash investing activities - Property
and equipment recorded in accounts payable and accrued expenses $ 214 $ 510 $ 998
Supplemental disclosure - Cash paid for interest $ 873 $ 836 $ 324

Supplemental disclosure - Non-cash investing activities -

Contingent Consideration

$ - $ 5,100 $ -
Supplemental disclosure - Cash paid for taxes $ 1,636 $ 514 $ 403
Property and equipment acquired under capital leases $ 363 $ 4,538 $ 3,795

athenahealth, Inc.

STOCK-BASED COMPENSATION EXPENSE

(Unaudited, in thousands)

Set forth below is a breakout of stock-based compensation expense for the three months and year ended December 31, 2010 and 2009:

(unaudited, in thousands) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
Stock-based compensation charged to:
Direct operating $ 577 $ 414 $ 2,298 $ 1,589
Selling and marketing 969 548 3,509 2,126
Research and development 542 266 2,014 1,015
General and administrative 1,934 971 6,656 3,584
Total $ 4,022 $ 2,199 $ 14,477 $ 8,314

athenahealth, Inc.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES
(Unaudited, in thousands, except per share amounts)

The following is a reconciliation of the non-GAAP financial measures used by the Company to describe the Company's financial results determined in accordance with United States generally accepted accounting principles (GAAP). An explanation of these measures is also included below under the heading "Explanation of Non-GAAP Financial Measures".

While management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying performance of the Company's business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company's results of operations as determined in accordance with GAAP.

Non-GAAP Adjusted Gross Margin

Set forth below is a presentation of the Company's "Non-GAAP Adjusted Gross Profit" and "Non-GAAP Adjusted Gross Margin," which represents Non-GAAP Adjusted Gross Profit as a percentage of total revenue.

(unaudited, in thousands) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
Total revenue $ 69,366 $ 54,446 $ 245,538 $ 188,527
Direct operating expense 24,419 21,117 96,582 79,017
Total revenue less direct
operating expense 44,947 33,329 148,956 109,510
Add: Stock-based compensation expense allocated to direct operating expense
577 414 2,298 1,589
Add: Amortization of purchased intangibles 460 396 1,839 635
Non-GAAP Adjusted Gross Profit $ 45,984 $ 34,139 $ 153,093 $ 111,734
Non-GAAP Adjusted Gross Margin 66.3 % 62.7 % 62.4 % 59.3 %

Non-GAAP Adjusted EBITDA Margin

Set forth below is a reconciliation of the Company's "Non-GAAP Adjusted EBITDA" and "Non-GAAP Adjusted EBITDA Margin," which represents Non-GAAP Adjusted EBITDA as a percentage of total revenue.

(unaudited, in thousands) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
Total revenue $ 69,366 $ 54,446 $ 245,538 $ 188,527
GAAP net income 7,303 4,328 12,704 9,276
Add: Provision for income taxes 5,330 3,879 10,396 8,829
Add: Acquisition-related expenses - 100 - 751
Add (less): Total other (income) expense (100 ) (96 ) 497 (893 )
Add: Stock-based compensation expense 4,022 2,199 14,477 8,314
Add: Depreciation and amortization 3,171 2,232 11,117 7,767
Add: Amortization of purchased intangibles 460 396 1,839 635
Non-GAAP Adjusted EBITDA $ 20,186 $ 13,038 $ 51,030 $ 34,679
Non-GAAP Adjusted EBITDA Margin 29.1 % 23.9 % 20.8 % 18.4 %

Non-GAAP Adjusted Operating Income

Set forth below is a reconciliation of the Company's "Non-GAAP Adjusted Operating Income" and "Non-GAAP Adjusted Operating Income Margin." Non-GAAP Adjusted Operating Income Margin represents Non-GAAP Adjusted Operating Income as a percentage of total revenue.

(unaudited, in thousands) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
Total revenue $ 69,366 $ 54,446 $ 245,538 $ 188,527
GAAP net income 7,303 4,328 12,704 9,276
Add: Provision for income taxes 5,330 3,879 10,396 8,829
Add: Acquisition-related expenses - 100 - 751
Add (less): Total other (income) expense (100 ) (96 ) 497 (893 )
Add: Stock-based compensation expense 4,022 2,199 14,477 8,314
Add: Amortization of purchased intangibles 460 396 1,839 635
Non-GAAP Adjusted Operating Income $ 17,015 $ 10,806 $ 39,913 $ 26,912
Non-GAAP Adjusted Operating Income Margin 24.5 % 19.8 % 16.3 % 14.3 %

Non-GAAP Adjusted Net Income

Set forth below is a reconciliation of the Company's "Non-GAAP Adjusted Net Income" and "Non-GAAP Adjusted Net Income per Diluted Share."

(unaudited, in thousands except per share amounts) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
GAAP net income $ 7,303 $ 4,328 $ 12,704 $ 9,276
(Less) Add: (Gain) loss on interest rate derivative contract (276 ) (215 ) 199 (590 )
Add: Stock-based compensation expense 4,022 2,199 14,477 8,314
Add: Amortization of purchased intangibles 460 396 1,839 635
Sub-total of tax deductible items 4,206 2,380 16,515 8,359
(Less): Tax impact of tax deductible items (1) (1,682 ) (952 ) (6,606 ) (3,344 )
Add: Acquisition-related expenses - 100 - 751
Non-GAAP Adjusted Net Income $ 9,827 $ 5,856 $ 22,613 $ 15,042
Weighted average shares - diluted 35,278 35,133 35,204 34,917
Non-GAAP Adjusted Net Income per Diluted Share $ 0.28 $ 0.17 $ 0.64 $ 0.43
(1) - Tax impact calculated using federal statutory tax rate of 34% and a blended state tax rate of 6%
(unaudited, in thousands except per share amounts) Three Months Ended Year Ended
December 31 December 31
2010 2009 2010 2009
GAAP net income per share - diluted $ 0.21 $ 0.12 $ 0.36 $ 0.27
(Less) Add: (Gain) loss on interest rate derivative contract (0.01 ) (0.01 ) 0.01 (0.02 )
Add: Stock-based compensation expense 0.12 0.06 0.41 0.24
Add: Amortization of purchased intangibles 0.01 0.01 0.05 0.02
Sub-total of tax deductible items 0.12 0.06 0.47 0.24
(Less): Tax impact of tax deductible items (1) (0.05 ) (0.02 ) (0.19 ) (0.10 )
Add: Acquisition-related expenses - 0.01 - 0.02
Non-GAAP Adjusted Net Income per Diluted Share $ 0.28 $ 0.17 $ 0.64 $ 0.43
Weighted average shares - diluted 35,278 35,133 35,204 34,917
(1) - Tax impact calculated using federal statutory tax rate of 34% and a blended state tax rate of 6%

Explanation of Non-GAAP Financial Measures

The Company reports its financial results in accordance with United States generally accepted accounting principles, or GAAP. However, management believes that in order to properly understand the Company's short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that vary in frequency and/or impact on continuing operations. Management also uses results of operations before such items to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in the Company's ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of the Company's ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing the Company's financial and operational performance and comparing this performance to its peers and competitors.

Management defines "Non-GAAPAdjusted Gross Profit" as total revenue, less direct operating expense, plus stock-based compensation expense allocated to direct operating expense and amortization of purchased intangibles, and "Non-GAAPAdjusted Gross Margin" as Non-GAAP Adjusted Gross Profit as a percentage of total revenue. Management considers these non-GAAP financial measures to be important indicators of the Company's operational strength and performance of its business and a good measure of its historical operating trends. Moreover, management believes that these measures enable investors and financial analysts to closely monitor and understand changes in the Company's ability to generate income from ongoing business operations.

Management defines "Non-GAAPAdjusted EBITDA" as the sum of GAAP net income before provision for income taxes, acquisition-related expenses, total other (income) expense, stock-based compensation expense, depreciation and amortization, and amortization of purchased intangibles and "Non-GAAPAdjusted EBITDA Margin" as Non-GAAP Adjusted EBITDA as a percentage of total revenue. Management defines "Non-GAAPAdjusted Operating Income" as the sum of GAAP net income before provision for income taxes, amortization of purchased intangibles, acquisition-related expenses, total other (income) expense, stock-based compensation expense, and "Non-GAAPAdjusted Operating Income Margin" as Non-GAAP Adjusted Operating Income as a percentage of total revenue. Management defines "Non-GAAPAdjusted Net Income" as the sum of GAAP net income before (gain) loss on interest rate derivative contract, stock-based compensation expense, amortization of purchased intangibles, acquisition-related expenses, , and any tax impact related to these items, and "Non-GAAPAdjusted Net Income per Diluted Share" as Non-GAAP Adjusted Net Income divided by weighted average diluted shares outstanding. Management considers these non-GAAP financial measures to be important indicators of the Company's operational strength and performance of its business and a good measure of its historical operating trends, in particular the extent to which ongoing operations impact the Company's overall financial performance.

Management excludes each of the items identified below from the applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item:

  • Stock-based compensation expense -- excluded because these are non-cash expenses that management does not consider part of ongoing operating results when assessing the performance of the Company's business, and also because the total amount of expense is partially outside of the Company's control because it is based on factors such as stock price volatility and interest rates, which may be unrelated to our performance during the period in which the expense is incurred.
  • Acquisition-related expenses and amortization of purchased intangibles -- acquisition-related expenses are reported at the time acquisition costs are incurred, and purchased intangibles are amortized over a period of several years after the acquisition and generally cannot be changed or influenced by management after the acquisition. Accordingly, these items are not considered by management in making operating decisions, and management believes that such expenses do not have a direct correlation to future business operations. Thus, including such charges does not accurately reflect the performance of the Company's ongoing operations for the period in which such charges are incurred.
  • Gains and losses on interest rate derivative contract -- excluded because until they are realized, to the extent these gains or losses impact a period presented, management does not believe that they reflect the underlying performance of ongoing business operations for such period.

SOURCE: athenahealth, Inc.

athenahealth, Inc.
Jennifer Heizer (Investors), 617-402-1322
Director, Investor Relations
investorrelations@athenahealth.com
or
John Hallock (Media), 617-402-1428
Director, Corporate Communications
media@athenahealth.com

Download PDF Download PDF
  • Email Alerts
  • Latest from Twitter

    @athenahealth
    Follow us